Home/Eikon Therapeutics/Dr. Xavier Reveles
DX

Dr. Xavier Reveles

Chief Business Officer

Eikon Therapeutics

Therapeutic Areas

Eikon Therapeutics Pipeline

DrugIndicationPhase
EIK-001Oncology (Undisclosed)Preclinical
EIK-002Immunology/Inflammation (Undisclosed)Preclinical
EIK-003Oncology (Undisclosed)Discovery
EIK-004UndisclosedDiscovery
EIK-005UndisclosedDiscovery